Antonio Evidente Selected Research

Antonio Evidente Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 05/2006
11	Necrosis 11/2021 - 04/2002
11	Melanoma (Melanoma, Malignant) 10/2021 - 10/2009
10	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 10/2009
7	Glioma (Gliomas) 10/2021 - 05/2012
6	Infections 04/2021 - 03/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 03/2013
2	Mycoses (Diseases, Fungus) 08/2022 - 01/2018
2	Dengue (Dengue Fever) 01/2021 - 01/2017
2	Lung Neoplasms (Lung Cancer) 04/2015 - 10/2009
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Blister (Bulla) 04/2018
1	Yellow Fever 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2016
1	Kidney Neoplasms (Kidney Cancer) 10/2015
1	Sarcoma (Soft Tissue Sarcoma) 04/2015
1	Brain Neoplasms (Brain Tumor) 03/2013

Drug/Important Bio-Agent (IBA)

12	AlkaloidsIBA 01/2022 - 10/2009
8	ophiobolin AIBA 10/2021 - 03/2006
8	Pharmaceutical PreparationsIBA 09/2016 - 05/2012
7	Cytostatic AgentsIBA 02/2018 - 11/2010
6	lycorineIBA 01/2022 - 10/2009
5	Biological ProductsIBA 01/2021 - 12/2011
4	AminesIBA 10/2021 - 10/2015
3	polygodialIBA 10/2021 - 10/2015
3	sphaeropsidin AIBA 10/2020 - 10/2015
3	Amaryllidaceae AlkaloidsIBA 01/2018 - 07/2010
3	hemanthamineIBA 01/2018 - 07/2010
3	narciclasineIBA 09/2017 - 11/2010
2	hemanthidineIBA 01/2022 - 07/2010
2	EstersIBA 10/2021 - 04/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2015
2	DiterpenesIBA 12/2019 - 04/2013
2	jonquailineIBA 09/2018 - 04/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 10/2015
2	Temozolomide (Temodar)FDA LinkGeneric 05/2017 - 01/2011
2	AnionsIBA 05/2017 - 10/2015
2	crinineIBA 09/2016 - 05/2012
2	SesquiterpenesIBA 12/2015 - 10/2015
2	fusicoccinIBA 04/2013 - 07/2010
1	pachybasinIBA 08/2022
1	pancracineIBA 01/2022
1	4-hydroxyphenylethanolIBA 11/2021
1	ochracinIBA 04/2021
1	BenzoquinonesIBA 04/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	14-3-3 Proteins (14-3-3 Protein)IBA 01/2021
1	N- (4- hydroxy- beta- phenethyl)- 4- hydroxycinnamideIBA 01/2021
1	cheryllineIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	SolutionsIBA 01/2020
1	PyronesIBA 12/2019
1	Protein SIBA 01/2019
1	phosphatidylethanolamineIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	LipidsIBA 01/2019
1	Fusaric AcidIBA 10/2018
1	3-phenyllactic acidIBA 04/2018
1	Histones (Histone)IBA 02/2018
1	TubulinIBA 02/2018
1	Sirtuin 1IBA 02/2018
1	montanineIBA 01/2018
1	lipid-associated sialic acid (LASA)IBA 01/2018
1	LipopolysaccharidesIBA 08/2017
1	O Antigens (O Antigen)IBA 08/2017
1	Cisplatin (Platino)FDA LinkGeneric 05/2017
1	CaspasesIBA 03/2017
1	sapinofuranone BIBA 10/2016
1	5,10b-ethanophenanthridineIBA 09/2016
1	spinasterolIBA 03/2016
1	2-methoxy-1,4-naphthoquinoneIBA 03/2016
1	SteroidsIBA 03/2016
1	Fixatives (Pickling Agents)IBA 10/2015
1	PyrrolesIBA 10/2015
1	phomentrioloxin BIBA 04/2015
1	3-nitropropionic acidIBA 04/2015
1	gulypyrone AIBA 04/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2015
1	pretazettineIBA 04/2015
1	Virulence Factors (Pathogenicity Factors)IBA 03/2014
1	Dihydrotachysterol (AT 10)IBA 08/2013
1	Cardiac GlycosidesIBA 04/2013
1	Adenosine Triphosphatases (ATPase)IBA 04/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2013
1	hellebrigeninIBA 04/2013
1	BufanolidesIBA 04/2013
1	CardenolidesIBA 04/2013
1	hellebrinIBA 04/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2013
1	GlucosidesIBA 04/2013
1	Tyrosine (L-Tyrosine)FDA Link 04/2013
1	Phosphotransferases (Kinase)IBA 04/2013
1	Guanosine Triphosphate (GTP)IBA 03/2013

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 04/2013
3	Therapeutics 01/2020 - 11/2010
2	Punctures 10/2018 - 02/2017
1	Traditional Medicine (Folk Remedies) 01/2018
1	Radiotherapy 04/2013